BJL
AZN icon

Brighton Jones LLC’s AstraZeneca AZN Stock Holding History

Brighton Jones LLC’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$797K Buy
4,201
+290
+7% +$54.5K 0.01% 597
2026
Q1 		$771K Buy
+3,911
New +$754K 0.02% 544
2025
Q4 		– Sell
-3,429
Closed -$526K – 136
2025
Q3 		$526K Buy
3,429
+28
+0.8% +$4.24K 0.01% 609
2025
Q2 		$475K Buy
3,401
+515
+18% +$72.2K 0.01% 558
2025
Q1 		$424K Sell
2,886
-5
-0.2% -$723 0.01% 441
2024
Q4 		$379K Buy
2,891
+1,394
+93% +$195K 0.01% 462
2024
Q3 		$233K Sell
1,497
-704
-32% -$114K 0.01% 495
2024
Q2 		$343K Sell
2,201
-64
-3% -$9.63K 0.01% 443
2024
Q1 		$307K Buy
2,265
+30
+1% +$3.97K 0.01% 459
2023
Q4 		$301K Buy
2,235
+501
+29% +$65.1K 0.01% 444
2023
Q3 		$235K Buy
1,734
+75
+5% +$10.2K 0.01% 463
2023
Q2 		$237K Buy
+1,659
New +$244K 0.01% 460

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brighton Jones LLC's AZN Position: Q2 2026 in Review

Brighton Jones LLC increased its AstraZeneca (AZN) stake by 7.4% in Q2 2026, buying an estimated $54.5K and bringing the position to 4,201 shares worth $797K. The position accounts for 0.01% of the portfolio, ranked #597.

Brighton Jones LLC first reported a position in AZN in Q2 2023 and has held it in 12 quarters since. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Brighton Jones LLC held 4,201 shares of AstraZeneca worth $797K as of Q2 2026.
  • Brighton Jones LLC bought 290 AstraZeneca shares in Q2 2026, an estimated $54.5K.
  • AstraZeneca made up 0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #597 holding.
  • Brighton Jones LLC first reported a position in AstraZeneca in Q2 2023 and has held it in 12 quarters since.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.